Publication
Efavirenz Concentrations in HIV-Infected Patients With and Without Viral Hepatitis
dc.contributor.author | Pereira, SA | |
dc.contributor.author | Caixas, U | |
dc.contributor.author | Branco, T | |
dc.contributor.author | Germano, I | |
dc.contributor.author | Lampreia, F | |
dc.contributor.author | Papoila, AL | |
dc.contributor.author | Monteiro, E | |
dc.date.accessioned | 2014-04-08T11:47:00Z | |
dc.date.available | 2014-04-08T11:47:00Z | |
dc.date.issued | 2008 | |
dc.description.abstract | AIMS: Data on efavirenz in HIV/viral hepatitis co-infected patients is non-consensual, probably due to liver function heterogeneity in the patients included. METHODS: A case control study was performed on 27 HIV-infected patients, with controlled and homogenous markers of hepatic function, either mono-infected or co-infected with HBV/HCV, to ascertain the influence of viral hepatitis on efavirenz concentrations over a 2-year follow-up period. RESULTS: No differences were found in efavirenz concentrations between groups both during and at the end of the follow-up period: control (2.43 +/- 1.91 mg l(-1)) vs. co-infected individuals (2.37 +/- 0.37 mg l(-1)). CONCLUSION: It was concluded that HBV/HCV infections in themselves do not predispose to an overexposure to efavirenz. | por |
dc.identifier.citation | Br J Clin Pharmacol. 2008 Oct;66(4):551-5 | por |
dc.identifier.uri | http://hdl.handle.net/10400.17/1776 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.publisher | Wiley | por |
dc.subject | CHLC MED | por |
dc.subject | Doenças Hepáticas | por |
dc.subject | Inibidores de Transcriptase Reversa | por |
dc.subject | Projectos Piloto | por |
dc.subject | Índice de Gravidade da Doença | por |
dc.subject | Resultado de Tratamento | por |
dc.subject | Carga Viral | por |
dc.subject | Infecções Oportunistas Relacionadas com a SIDA | por |
dc.subject | Benzoxazinas | por |
dc.subject | Contagem de Linfócito CD4 | por |
dc.subject | Estudos de Casos e Controles | por |
dc.subject | Evolução da Doença | por |
dc.subject | Relação Dose-Resposta a Medicamento | por |
dc.subject | Monitorização de Medicamentos | por |
dc.subject | Estudos de Follow-Up | por |
dc.subject | Infecção por HIV | por |
dc.subject | Hepatite B Crónica | por |
dc.subject | Hepatite C Crónica | por |
dc.subject | Metabolismo | por |
dc.title | Efavirenz Concentrations in HIV-Infected Patients With and Without Viral Hepatitis | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 555 | por |
oaire.citation.startPage | 551 | por |
oaire.citation.title | British Journal of Clinical Pharmacology | por |
rcaap.rights | openAccess | por |
rcaap.type | article | por |